Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.48 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4138068 | 0.87 | PPARA (0.47) | PPARACYSLTR2FAAHPPARGEPHX2 | |
| SCHEMBL3299520 | 0.80 | RELA (0.53) | FAAHEPHX2 | |
| SCHEMBL8094109 | 0.79 | THRB (0.58) | THRBTHRAHDAC1HDAC8KDM4E | |
| SCHEMBL10745530 | 0.77 | APP (0.47) | FAAHEPHX2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10745504 | 0.77 | APP (0.47) | FAAHEPHX2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10745545 | 0.77 | APP (0.47) | FAAHEPHX2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10745536 | 0.77 | APP (0.47) | FAAHEPHX2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL16535943 | 0.77 | LCK (0.49) | — | |
| SCHEMBL16679898 | 0.77 | LCK (0.49) | — | |
| SCHEMBL16974816 | 0.77 | LCK (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | SOARES ROMEIRO LUIZ ANTONIO | 2009-03-12 | — | — | US | disclosed |
| EP-1812027-A2 | COMPOUNDS CAPABLE OF ABSORBING ULTRAVIOLET RADIATION, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | Universidade Federal Do Rio De Janeiro - UFRJ (BR) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006042391-A2 | PHOTOPROTECTIVE PHENOL DERIVATIVES OBTAINED FROM CASHEW NUT-SHELL LIQUID | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) | 2006-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | S100A10, CD63, S100A9 | THRB 4202/4885THRA 3848/4885PPARA 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.